Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis
Objective: Soluble CD40 (sCD40) is a potential modulator for both antitumor responses and CD40-based immunotherapy; however the levels and significance of sCD40 in non-small cell lung cancer (NSCLC) patients with malignant pleural effusion are unknown. Methods: Forty-eight patients with lung cancer...
Saved in:
Main Authors: | Chuan-Yong Mu, Pang-Xue Qin, Qiu-Xia Qu, Cheng Chen, Jian-An Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
KeAi Communications Co., Ltd.
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/329cb7b479a049c5a57f6d5c4e23ac55 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutant KRAS promotes malignant pleural effusion formation
by: Theodora Agalioti, et al.
Published: (2017) -
The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study
by: Katrine Fjaellegaard, et al.
Published: (2021) -
Single-cell analysis of diverse immune phenotypes in malignant pleural effusion
by: Zhong-Yin Huang, et al.
Published: (2021) -
The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion
by: Ke-Cheng Chen, et al.
Published: (2021) -
Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
by: Marazioti A, et al.
Published: (2019)